Please use this identifier to cite or link to this item:
Title: Malaria preventive therapy in pregnancy and its potential impact on immunity to malaria in an area of declining transmission
Author: Teo, Andrew
Hasang, Wina
Randall, Louise M.
Unger, Holger W.
Siba, Peter
Mueller, Ivo
Brown, Graham V.
Rogerson, Stephen J.
Keywords: Malària
Plasmodium falciparum
Plasmodium falciparum
Issue Date: 26-May-2015
Publisher: BioMed Central
Abstract: BACKGROUND: Regular anti-malarial therapy in pregnancy, a pillar of malaria control, may affect malaria immunity, with therapeutic implications in regions of reducing transmission. METHODS: Plasma antibodies to leading vaccine candidate merozoite antigens and opsonizing antibodies to endothelial-binding and placental-binding infected erythrocytes were quantified in pregnant Melanesian women receiving sulfadoxine-pyrimethamine (SP) with chloroquine taken once, or three courses of SP with azithromycin. RESULTS: Malaria prevalence was low. Between enrolment and delivery, antibodies to recombinant antigens declined in both groups (p < 0.0001). In contrast, median levels of opsonizing antibodies did not change, although levels for some individuals changed significantly. In multivariate analysis, the malaria prevention regimen did not influence antibody levels. CONCLUSION: Different preventive anti-malarial chemotherapy regimens used during pregnancy had limited impact on malarial-immunity in a low-transmission region of Papua New Guinea. TRIAL REGISTRATIONS: NCT01136850.
Note: Reproducció del document publicat a:
It is part of: Malaria Journal, 2015, vol. 14, num. 215, 8 p.
Related resource:
ISSN: 1475-2875
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
teo2015_1888.pdf469.79 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons